GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Cash Flow for Lease Financing

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Cash Flow for Lease Financing : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Cash Flow for Lease Financing?

China Resources Double-Crane Pharmaceutical Co's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ¥0 Mil. China Resources Double-Crane Pharmaceutical Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Compared with last quarter (¥0 Mil in Dec. 2023 ), China Resources Double-Crane Pharmaceutical Co's Cash Flow for Lease Financing remained the same in Mar. 2024 (¥0 Mil).

China Resources Double-Crane Pharmaceutical Co Cash Flow for Lease Financing Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Cash Flow for Lease Financing Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China Resources Double-Crane Pharmaceutical Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Double-Crane Pharmaceutical Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Cash Flow for Lease Financing
Comparable Companies
SHSE:600380 SHSE:600329 SZSE:300601 SHSE:600535 SHSE:603707 SHSE:600521 SZSE:300142 SHSE:600867 SHSE:600129 SZSE:002262 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
Website
http://www.dcpc.com
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines